Safety and efficacy of PD-1/PD-L1 inhibitors combined with albumin-bound paclitaxel and fluorouracil-based agents as second-line therapy in biliary tract cancers

Abstract Background Biliary tract cancers (BTCs) are a group of highly aggressive malignancies with limited therapeutic options. Gemcitabine plus cisplatin (GemCis) remains the standard first-line regimen; however, the efficacy of currently recommended second-line therapies remains unsatisfactory. I...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Xiao Wang, Ying Zha, Pengen Li, Shumin Fu, Lin Xu, Weimin Jiang, Jianbing Wu, Ye Mao
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	BMC 2026-05-01
Σειρά:	World Journal of Surgical Oncology
Θέματα:	Albumin-bound paclitaxel Biliary tract cancers Immunotherapy Second-line therapy
Διαθέσιμο Online:	https://doi.org/10.1186/s12957-026-04393-5
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!